Segall Bryant & Hamill, LLC
- SEC CIK
- 0001006378
- Latest filing
- Aug 12, 2026
LKFT holding history
Lakefront Biotherapeutics NV in every 13F filed by Segall Bryant & Hamill, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LKFT overviewAll 13F holders of LKFTFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −426,412−100.0% | Sold out | Holders |
| Q1 2026 | 426,412 | $12.8M | 0.2% | −21,684−4.8% | Reduced | Holders |
| Q4 2025 | 448,096 | $14.7M | 0.2% | −39,100−8.0% | Reduced | Holders |
| Q3 2025 | 487,196 | $16.9M | 0.2% | −13,881−2.8% | Reduced | Holders |
| Q2 2025 | 501,077 | $14.0M | 0.2% | −150,384−23.1% | Reduced | Holders |
| Q1 2025 | 651,461 | $16.4M | 0.3% | −34,406−5.0% | Reduced | Holders |
| Q4 2024 | 685,867 | $18.9M | 0.3% | −19,781−2.8% | Reduced | Holders |
| Q3 2024 | 705,648 | $20.3M | 0.3% | −93,431−11.7% | Reduced | Holders |
| Q2 2024 | 799,079 | $19.8M | 0.4% | −68,963−7.9% | Reduced | Holders |
| Q1 2024 | 868,042 | $28.0M | 0.5% | −6,686−0.8% | Reduced | Holders |
| Q4 2023 | 874,728 | $35.6M | 0.7% | +136,737+18.5% | Added | Holders |
| Q3 2023 | 737,991 | $25.5M | 0.3% | +346,630+88.6% | Added | Holders |
| Q2 2023 | 391,361 | $15.9M | 0.2% | +91,970+30.7% | Added | Holders |
| Q1 2023 | 299,391 | $11.6M | 0.1% | +299,391 | New | Holders |